SHAP vs. EVH, TIXT, NXTT, EEX, YEXT, IBTA, IIIV, FVRR, PRSU, and RSKD
Should you be buying Spree Acquisition Corp. 1 stock or one of its competitors? The main competitors of Spree Acquisition Corp. 1 include Evolent Health (EVH), Telus Digital (TIXT), Next Technology (NXTT), Emerald (EEX), Yext (YEXT), Ibotta (IBTA), i3 Verticals (IIIV), Fiverr International (FVRR), Pursuit Attractions and Hospitality (PRSU), and Riskified (RSKD). These companies are all part of the "business services" industry.
Spree Acquisition Corp. 1 vs. Its Competitors
Spree Acquisition Corp. 1 (NYSE:SHAP) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.
9.9% of Spree Acquisition Corp. 1 shares are held by institutional investors. 58.4% of Spree Acquisition Corp. 1 shares are held by company insiders. Comparatively, 1.4% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Spree Acquisition Corp. 1 has a net margin of 0.00% compared to Evolent Health's net margin of -4.54%. Evolent Health's return on equity of 3.64% beat Spree Acquisition Corp. 1's return on equity.
Spree Acquisition Corp. 1 has higher earnings, but lower revenue than Evolent Health.
Spree Acquisition Corp. 1 has a beta of -0.02, indicating that its stock price is 102% less volatile than the S&P 500. Comparatively, Evolent Health has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500.
In the previous week, Evolent Health had 1 more articles in the media than Spree Acquisition Corp. 1. MarketBeat recorded 1 mentions for Evolent Health and 0 mentions for Spree Acquisition Corp. 1. Evolent Health's average media sentiment score of 0.62 beat Spree Acquisition Corp. 1's score of 0.00 indicating that Evolent Health is being referred to more favorably in the news media.
Evolent Health has a consensus target price of $17.93, indicating a potential upside of 81.21%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than Spree Acquisition Corp. 1.
Summary
Evolent Health beats Spree Acquisition Corp. 1 on 9 of the 14 factors compared between the two stocks.
Get Spree Acquisition Corp. 1 News Delivered to You Automatically
Sign up to receive the latest news and ratings for SHAP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SHAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spree Acquisition Corp. 1 Competitors List
Related Companies and Tools
This page (NYSE:SHAP) was last updated on 7/25/2025 by MarketBeat.com Staff
Free SHAP Stock Alerts